Pharmaceutical

Tenon Medical(R) Announces Pricing of At-The-Market PIPE Financing

~ Strategically Placed PIPE With Industry Supportive Investor Cohort ~ LOS GATOS, CA / ACCESS Newswire / November 11, 2025…

1 month ago

AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture

Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™.Reinforces competitive advantage as the…

1 month ago

Zomedica Announces “Friday at Four” Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review

November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN…

1 month ago

Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025

24-week data demonstrated significant MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile…

1 month ago

Mentavi Health Introduces “Mentavi Concierge” – Setting a New Standard for Responsible AI in Digital Health

Built for trust and compliance, the AI support assistant streamlines intake and routes visitors and patients to human‑led care. GRAND…

1 month ago

SoftWriters Launches Alpha Labs Team to Advance AI and Automation Innovation

New cross-functional "Alpha Labs" team will fast-track AI and automation capabilities from concept to product, helping long-term care pharmacies work…

1 month ago

Cosmo’s ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal

Dublin, Ireland--(Newsfile Corp. - November 11, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and…

1 month ago

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",…

1 month ago

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",…

1 month ago

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /…

1 month ago